Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

58.89 +1.08 (+1.87%)
Streaming Delayed Price Updated: 10:47 AM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Why Artificial Intelligence Stock Tempus AI Is Tumbling Today
An investment management firm known for short-selling the stocks it speaks against is now targeting a high-risk, high-reward stock purchased by a high-profile politician. 
Via The Motley Fool
Topics Artificial Intelligence
Top movers analysis in the middle of the day on 2025-05-28: top gainers and losers in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Tempus AI Stock Sinks On Spruce Point’s Short Report
The report stated that Tempus AI’s management and board members have a history of promoting “disruptive technology companies” and cashing out early. 
Via Stocktwits
Topics Artificial Intelligence
Crude Oil Gains 2%; Macy's Lowers Earnings Forecast
Via Benzinga
Tempus Fugit, Investors Regret? Short Seller Targets AI Darling, Warns CEO Is 'Cash Out King'
Spruce Point Capital Management has announced a new short position against Tempus AI Inc (NASDAQ:TEM). The short seller on Wednesday raised concerns around the company's management team and... 
Via Benzinga
Topics Artificial Intelligence
These stocks are gapping in today's session
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
A Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 Years
From Tempus AI, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit
Cathie Wood underscored the application of AI in the healthcare sector by sharing new research by Mass General Brigham. 
Via Benzinga
Topics Artificial Intelligence
New Study Shows Impact of Ambry Genetics’ Patient for Life™ Program on Rare Disease Diagnosis
From Ambry Genetics
Via Business Wire
8 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Treasury Yields Top 5%: These 20 Stocks Tanked In Just One Hour
The selloff came as investors repriced risk across equities amid fears of persistently higher rates, sparked by soft demand at the 20-year Treasury auction. 
Via Benzinga
Tempus to Present at the William Blair 45th Annual Growth Stock Conference
From Tempus AI, Inc.
Via Business Wire
Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment
From Tempus AI, Inc.
Via Business Wire
Beyond The Numbers: 11 Analysts Discuss Tempus AI Stock
 
Via Benzinga
Topics Artificial Intelligence
Tempus Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline
From Tempus AI, Inc.
Via Business Wire
Tempus Announces Six Posters Accepted for Presentation at ISPOR 2025
From Tempus AI, Inc.
Via Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (and Sold)
Via The Motley Fool
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:POAI),(NYSE:TDOC),(NASDAQ:GEHC) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space. 
Via Benzinga
Topics Artificial Intelligence
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
From FN Media Group LLC
Via GlobeNewswire
MarketBeat Week in Review – 05/05 - 05/09
Equities turned bullish this week on renewed hopes for progress in trade deals; next week's inflation readings could be a market mover 
Via MarketBeat
Topics Artificial Intelligence Economy Government
Investing in CoreWeave: Key Insights on the NVIDIA‑Backed AI IPO
CoreWeave is arguably the most talked-about new stock in 2025. What is to make of this AI cloud infrastructure firm with a significant investment from NVIDIA? 
Via MarketBeat
Topics Artificial Intelligence
Tempus AI Stock: Time to Double Down or Cut and Run?
Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point to significant upside potential. 
Via MarketBeat
Topics Artificial Intelligence
Cathie Wood Strengthens AI Chip Holdings With Nvidia And AMD Purchases, Reduces Palantir Position By Another $38.8 Million
On Wednesday, May 7, 2025, Cathie Wood's Ark Invest Pours $24M Into Nvidia and AMD While Offloading $38.8M in Palantir Shares. 
Via Benzinga
Topics Artificial Intelligence
Tempus AI Rallies After Q1 Beat, Analyst Notes AI-Driven Platform And Expanding Pharma Deals
Tempus AI shares rose after a Q1 beat, as an analyst highlighted its AI-driven growth, expanding pharma deals, and $1B+ contract value. 
Via Benzinga
Topics Artificial Intelligence
Warren Buffett Falls Behind Nancy Pelosi In Stock Market Returns Over The Last 11 Years: Here's What Data Shows
Nancy Pelosi's investments over 11 years have outperformed the 'Oracle of Omaha', Warren Buffett's Berkshire Hathaway. 
Via Benzinga
Cathie Wood-Backed Tempus AI Says Pharma Contracts Solid Despite Biotech Funding Challenges, Tariff Pressures
Tempus AI reassured investors that its major pharma contracts remain strong despite funding and tariff pressures. 
Via Benzinga
Topics Artificial Intelligence World Trade
Tempus AI Strikes $200M Deal With AstraZeneca, Pathos To Build World's Largest Oncology Model
The biggest strategic highlight for Tempus AI Inc. (NASDAQ: TEM) during the first quarter was a multi-million dollar deal to build "the world's largest foundation model for oncology." 
Via Benzinga
Topics Artificial Intelligence
Tempus AI Q1 Earnings: Revenue Beat, EPS Beat, Raised FY Guidance, Shares Surge
Tempus AI reports first-quarter revenue of $255.74 million, beating estimates of $248.13 million. The AI-focused precision medicine and patient care company reports a first-quarter adjusted loss of 24... 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.